Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-11-13
DOI
10.3389/fimmu.2017.01554
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glycosylation of IgG-Fc: a molecular perspective
- (2017) Masato Kiyoshi et al. INTERNATIONAL IMMUNOLOGY
- Potent In Vivo NK Cell-Mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-Bispecific and Hexavalent Broadly Neutralizing Fusion Protein
- (2017) Ariola Bardhi et al. JOURNAL OF VIROLOGY
- Chemoenzymatic synthesis of glycoengineered IgG antibodies and glycosite-specific antibody–drug conjugates
- (2017) Feng Tang et al. Nature Protocols
- Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
- (2017) Liming Liu Protein & Cell
- Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy
- (2017) Yusuke Mimura et al. Protein & Cell
- Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity
- (2017) Benjamin Peschke et al. Frontiers in Immunology
- Optimal Synthetic Glycosylation of a Therapeutic Antibody
- (2016) Thomas B. Parsons et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Effect of Fc-Glycan Structure on the Conformational Stability of IgG Revealed by Hydrogen/Deuterium Exchange and Limited Proteolysis
- (2016) Jing Fang et al. BIOCHEMISTRY
- Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies
- (2016) Ngoc Phuong Lan Le et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Regulation of antibody effector functions through IgG Fc N-glycosylation
- (2016) Isaak Quast et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Modulating carbohydrate–protein interactions through glycoengineering of monoclonal antibodies to impact cancer physiology
- (2016) Austin WT Chiang et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs
- (2016) Peiqing Zhang et al. DRUG DISCOVERY TODAY
- Antibody–drug conjugates for cancer therapy
- (2016) Anish Thomas et al. LANCET ONCOLOGY
- Antibodies to watch in 2017
- (2016) Janice M. Reichert mAbs
- Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1
- (2016) Weizao Chen et al. mAbs
- A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Antibody-drug conjugates: recent advances in conjugation and linker chemistries
- (2016) Kyoji Tsuchikama et al. Protein & Cell
- Chemoenzymatic Conjugation of Toxic Payloads to the Globally Conserved N-Glycan of Native mAbs Provides Homogeneous and Highly Efficacious Antibody–Drug Conjugates
- (2015) Remon van Geel et al. BIOCONJUGATE CHEMISTRY
- Inactivation of GDP-fucose transporter gene (Slc35c1) in CHO cells by ZFNs, TALENs and CRISPR-Cas9 for production of fucose-free antibodies
- (2015) Kah Fai Chan et al. Biotechnology Journal
- Using glyco-engineering to produce therapeutic proteins
- (2015) Martina Dicker et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Fc glycans of therapeutic antibodies as critical quality attributes
- (2015) Dietmar Reusch et al. GLYCOBIOLOGY
- The Current Status and Prospects of Antibody Engineering for Therapeutic Use: Focus on Glycoengineering Technology
- (2015) Rinpei Niwa et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins
- (2015) Liming Liu JOURNAL OF PHARMACEUTICAL SCIENCES
- Examination of Thermal Unfolding and Aggregation Profiles of a Series of Developable Therapeutic Monoclonal Antibodies
- (2015) Mark L. Brader et al. MOLECULAR PHARMACEUTICS
- The Structural Role of Antibody N-Glycosylation in Receptor Interactions
- (2015) Ganesh P. Subedi et al. STRUCTURE
- Inactivation of GDP-fucose transporter gene (Slc35c1) in CHO cells by ZFNs, TALENs and CRISPR-Cas9 for production of fucose-free antibodies
- (2015) Kah Fai Chan et al. Biotechnology Journal
- Preparation of Well-Defined Antibody-Drug Conjugates through Glycan Remodeling and Strain-Promoted Azide-Alkyne Cycloadditions
- (2014) Xiuru Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Diversity in structure and functions of antibody sialylation in the Fc
- (2014) T Shantha Raju et al. CURRENT OPINION IN BIOTECHNOLOGY
- Aglycosylated full-length IgG antibodies: steps toward next-generation immunotherapeutics
- (2014) Man-Seok Ju et al. CURRENT OPINION IN BIOTECHNOLOGY
- Antibody drug conjugates
- (2014) Beverly A. Teicher CURRENT OPINION IN ONCOLOGY
- Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar
- (2014) Zhongyu Zhu et al. mAbs
- Biopharmaceutical benchmarks 2014
- (2014) Gary Walsh NATURE BIOTECHNOLOGY
- Next-generation antibodies
- (2014) James B. Evans et al. NATURE REVIEWS DRUG DISCOVERY
- Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
- (2014) Valentin Goede et al. NEW ENGLAND JOURNAL OF MEDICINE
- RG7116, a Therapeutic Antibody That Binds the Inactive HER3 Receptor and Is Optimized for Immune Effector Activation
- (2013) C. Mirschberger et al. CANCER RESEARCH
- Glycosylation: impact, control and improvement during therapeutic protein production
- (2013) Ana Rita Costa et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Exceptionally Potent and Broadly Cross-Reactive, Bispecific Multivalent HIV-1 Inhibitors Based on Single Human CD4 and Antibody Domains
- (2013) W. Chen et al. JOURNAL OF VIROLOGY
- Site-specific antibody drug conjugates for cancer therapy
- (2013) Siler Panowski et al. mAbs
- Glycoproteomic Analysis of Antibodies
- (2013) Gerhild Zauner et al. MOLECULAR & CELLULAR PROTEOMICS
- Crystal structure of sialylated IgG Fc: Implications for the mechanism of intravenous immunoglobulin therapy
- (2013) M. Crispin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of orally active inhibitors of protein and cellular fucosylation
- (2013) N. M. Okeley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Revisiting the Role of Glycosylation in the Structure of Human IgG Fc
- (2012) M. Jack Borrok et al. ACS Chemical Biology
- Effective Phagocytosis of Low Her2 Tumor Cell Lines with Engineered, Aglycosylated IgG Displaying High FcγRIIa Affinity and Selectivity
- (2012) Sang Taek Jung et al. ACS Chemical Biology
- Isotype and glycoform selection for antibody therapeutics
- (2012) Roy Jefferis ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Function and 3D Structure of the N-Glycans on Glycoproteins
- (2012) Masamichi Nagae et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
- (2012) Takashi Ishida et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemoenzymatic Glycoengineering of Intact IgG Antibodies for Gain of Functions
- (2012) Wei Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The impact of glycosylation on monoclonal antibody conformation and stability
- (2012) Kai Zheng et al. mAbs
- With or Without Sugar? (A)glycosylation of Therapeutic Antibodies
- (2012) Dmitrij Hristodorov et al. MOLECULAR BIOTECHNOLOGY
- Emerging Technologies for Making Glycan-Defined Glycoproteins
- (2011) Lai-Xi Wang et al. ACS Chemical Biology
- Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy
- (2011) Sang Taek Jung et al. CURRENT OPINION IN BIOTECHNOLOGY
- Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans
- (2011) Tsunehiro Mizushima et al. GENES TO CELLS
- Enhanced sialylation of recombinant human erythropoietin in Chinese hamster ovary cells by combinatorial engineering of selected genes
- (2011) Y.-D. Son et al. GLYCOBIOLOGY
- High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans
- (2011) A. M. Goetze et al. GLYCOBIOLOGY
- Therapeutic antibodies: Market considerations, disease targets and bioprocessing
- (2011) John G. Elvin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors
- (2011) Luis G. Paz-Ares et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanism of Action of Type II, Glycoengineered, Anti-CD20 Monoclonal Antibody GA101 in B-Chronic Lymphocytic Leukemia Whole Blood Assays in Comparison with Rituximab and Alemtuzumab
- (2011) L. Bologna et al. JOURNAL OF IMMUNOLOGY
- Les anticorps EMABling®
- (2011) Rémi Urbain et al. M S-MEDECINE SCIENCES
- Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway
- (2011) Robert M. Anthony et al. NATURE
- Rapid High Yield Production of Different Glycoforms of Ebola Virus Monoclonal Antibody
- (2011) Alexandra Castilho et al. PLoS One
- Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose
- (2011) C. Ferrara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
- (2010) Tadeusz Robak et al. BIODRUGS
- Production of non-fucosylated antibodies by co-expression of heterologous GDP-6-deoxy-D-lyxo-4-hexulose reductase
- (2010) H. H. von Horsten et al. GLYCOBIOLOGY
- A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs
- (2010) Robert M. Anthony et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes
- (2010) Geoff Hale et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Production of therapeutic antibodies with controlled fucosylation
- (2010) Naoko Yamane-Ohnuki et al. mAbs
- Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins
- (2010) Darius Ghaderi et al. NATURE BIOTECHNOLOGY
- Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood
- (2009) Shigeru Iida et al. BMC CANCER
- Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcγRIIIb and MHC class II expression on the phagocytotic neutrophils
- (2009) Mami Shibata-Koyama et al. EXPERIMENTAL HEMATOLOGY
- The structural basis for catalytic function of GMD and RMD, two closely related enzymes from the GDP-d-rhamnose biosynthesis pathway
- (2009) Jerry D. King et al. FEBS Journal
- Disruption of the OCH1 and MNN1 genes decrease N-glycosylation on glycoprotein expressed in Kluyveromyces lactis
- (2009) Bo Liu et al. JOURNAL OF BIOTECHNOLOGY
- Glycosynthases Enable a Highly Efficient Chemoenzymatic Synthesis ofN-Glycoproteins Carrying Intact NaturalN-Glycans
- (2009) Wei Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Emerging methods for the production of homogeneous human glycoproteins
- (2009) Jamie R Rich et al. Nature Chemical Biology
- Glycosylation as a strategy to improve antibody-based therapeutics
- (2009) Roy Jefferis NATURE REVIEWS DRUG DISCOVERY
- Aglycosylated IgG variants expressed in bacteria that selectively bind Fc RI potentiate tumor cell killing by monocyte-dendritic cells
- (2009) S. T. Jung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action
- (2009) Royston Jefferis TRENDS IN PHARMACOLOGICAL SCIENCES
- The crystal structure of rabbit IgG-Fc
- (2008) Enrico Girardi et al. BIOCHEMICAL JOURNAL
- When binding is enough: nonactivating antibody formats
- (2008) Aran F Labrijn et al. CURRENT OPINION IN IMMUNOLOGY
- Terminal sugars of Fc glycans influence antibody effector functions of IgGs
- (2008) T Shantha Raju CURRENT OPINION IN IMMUNOLOGY
- Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins
- (2008) Alain Beck et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
- (2008) Christine H. Chung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure
- (2008) Richard Strasser et al. PLANT BIOTECHNOLOGY JOURNAL
- Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors
- (2008) S. L. Sazinsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
- (2008) R. M. Anthony et al. SCIENCE
- Glycosylation of Recombinant Antibody Therapeutics
- (2005) Royston Jefferis BIOTECHNOLOGY PROGRESS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation